This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
News
Find our latest news, conferences, exhibitions, and other events here.
-
[Press Release] Noul Supplies AI Diagnostic Platform miLab™ to Charité, Europe’s Leading University Hospital2025.10.28
-
[Press Release] Noul Secures FDA Registration for Cervical Cancer Diagnostic Cartridge2025.09.23
-
[Press Release] Noul Publishes Its Fifth Sustainability Report, Outlining a Vision for Growth and a Decade of Breakthroughs2025.06.30
- Noul Sustainability Report 2024-2025
2025.06.20
-
[Press Release] Noul Showcases AI-Powered Cervical Cancer Cell Screening Technology at NVIDIA GTC 20252025.03.19
-
[Press Release] Noul Demonstrates ‘Expert-Level’ AI Diagnostic Performance in Europe… Results from Spain’s Carlos III Health Institute2024.09.24
-
Noul Sustainability Report 2023-20242024.06.28
-
[Press Release] Noul Participates in a Malaria Project Initiated by U.S. CDC with Kenya Medical Research Institute2024.06.17
-
[Press Release] On-Device AI Healthcare Company Noul Announces 2 Clinical Performance Studies at Pan-African Malaria Conference2024.04.25
-
Noul, a top On-Device AI healthcare company, joins CancerX, a cancer-fighting project led by the U.S. White House2024.02.26
-
[Press Release] On-Device AI Healthcare Company Noul Becomes an Official Member of Swiss Malaria GroupOn-Device AI Healthcare Company Noul 2024.02.09
-
[Press Release] AI Diagnostic Platform Company Noul, unveils the result of Malaria study in Ethiopia and Ghana2023.10.23